← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 13, 2018Last known activity
Dec 31, 2022
Acquired by Coherus BioSciences on Sep 8, 2023
Timeline
2010s
- Jun 1, 2014
Surface Oncology— Founded
2020s
- Sep 8, 2023
Coherus BioSciences— Acquired By
Drugs by trial phase (7 distinct, 6 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT05635643Lead sponsorPhase 1/Phase 2Dec 31, 2022
- NCT05359861Lead sponsorPhase 2Apr 12, 2022
- NCT05359861Study chairPhase 2Apr 12, 2022
- NCT05177770Lead sponsorPhase 2Jan 17, 2022
- NCT05177770Study chairPhase 2Jan 17, 2022
- NCT04374877Lead sponsorPhase 1Apr 22, 2020
- NCT04374877Study chairPhase 1Apr 22, 2020
- NCT04336098Lead sponsorPhase 1Mar 16, 2020
- NCT04336098Study chairPhase 1Mar 16, 2020
- NCT03512340Study chairPhase 1Mar 13, 2018
- NCT03512340Lead sponsorPhase 1Mar 13, 2018
Details
- Founded
- Cambridge, MA, US Jun 1, 2014
- Last known activity
- Dec 31, 2022